N,N-dibenzyl-2-naphthylamine | 51336-08-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N,N-dibenzyl-2-naphthylamine
• 英文别名: 2-(N,N-dibenzylamino)naphthalene；N,N-Dibenzyl-β-naphthylamin；N,N-dibenzylnaphthalen-2-amine；dibenzyl-[2]naphthyl-amine；Dibenzyl-β-naphthylamin
• CAS: 51336-08-4
• 化学式: C₂₄H₂₁N
• 分子量: 323.437
• InChiKey: OZELIJAQTBDXFQ-UHFFFAOYSA-N

物化性质

• 熔点：
  117-118 °C
• 沸点：
  519.6±39.0 °C(Predicted)
• 密度：
  1.143±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N,N-dibenzyl-2-naphthylamine 在 palladium 10% on activated carbon 、 5% Rh/C 、 氢气 、 氧气 、 三氟乙酸 作用下， 以 甲醇 为溶剂， 反应 8.0h， 生成 1-[4-(N,N-dimethylamino)phenyl]-2-aminonaphthalene
  参考文献：
  名称：

  异质铑催化的好氧氧化脱氢交叉偶联：不对称联芳胺

  摘要：

  本文报道了芳基胺的第一个非均相催化的氧化脱氢交叉偶联。使用非均相Rh / C催化剂，在温和的好氧条件下，将2-萘胺类似物与各种富电子芳烃反应，从而以高收率和高选择性提供非对称联芳胺。该反应提供了温和，操作简单和有效的方法来合成联芳基，这对药物和材料化学很重要。

  DOI：

  10.1002/anie.201600400
• 作为产物：
  描述：

  二苄胺 在 potassium hydrogenphosphate trihydrate 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 N,N-dibenzyl-2-naphthylamine
  参考文献：
  名称：

  Transition-Metal-Free Electrophilic Amination of Arylboroxines

  摘要：

  A transition-metal-free strategy to construct C(sp(2))-N bonds using arylboroxines and O-benzoyl hydroxylamines as coupling partners has been developed. This transformation provides a useful method to access various aromatic amines.

  DOI：

  10.1021/ol301912a

文献信息

• Pyrazinyl-substituted naphthalene derivatives
  申请人：——

  公开号：US20010004669A1

  公开（公告）日：2001-06-21

  Compounds of the formula 1 where R 1 is of the formulae 2 R 2 is —R 4 , —O—R 4 , —O—S (O) 2 —R 4 , —NR 4 R 5 , R 4 —(CH 2 ) b —NH(C═X)—(CH 2 )—, R 4 —(CH 2 ) b —O(C═O)NH—(CH 2 ) c —(C═O)NH—, R 4 (C═O)NH—(C═O)NH—, —(CH 2 ) b —NH(C═X)—(CH 2 ) c —R 4 , R 4 —(CH 2 ) b —O(C═)—(CH 2 ) c —, —(CH 2 ) b —O(C═O)—(CH 2 ) c —R 4 , —NH(C═X)NH—R 4 , R 4 —O(C═O)O—, —O(C═)NH—R 4 , R 4 —O(C═O)NH—, —(CH 2 ) b —(C═0)—(CH 2 ) c —R 4 , —NH—S(O) 2 —R 4 , —C(OH)R 4 R 5 , —CH(OH)—R 4 , —(C═O)—NR 4 R 5 , —CN, —NO 2 , substituted C 1 to C 6 alkyl, substituted or unsubstituted C 1 to C 6 alkenyl, or substituted or unsubstituted C 1 to C 6 alkynyl, said substituted moieties substituted with a moiety of the formulae —R 4 , —R 4 R 5 , —O—R 4 , or —S(O) d —R 4 . These compounds are useful psychotherapeutics and are potent serotonin (5-HT 1 ) agonists and antagonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotranmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.

  公式1的化合物，其中R1是公式2，R2是—R4，—O—R4，—O—S(O)2—R4，—NR4R5，R4—(CH2)b—NH(C═X)—(CH2)c—，R4—(CH2)b—O(C═O)NH—(CH2)c—(C═O)NH—，R4(C═O)NH—(C═O)NH—，—(CH2)b—NH(C═X)—(CH2)c—R4，R4—(CH2)b—O(C═)—(CH2)c—，—(CH2)b—O(C═O)—(CH2)c—R4，—NH(C═X)NH—R4，R4—O(C═O)O—，—O(C═)NH—R4，R4—O(C═O)NH—，—(CH2)b—(C═O)—(CH2)c—R4，—NH—S(O)2—R4，—C(OH)R4R5，—CH(OH)—R4，—(C═O)—NR4R5，—CN，—NO2，取代的C1至C6烷基，取代或未取代的C1至C6烯基，或取代或未取代的C1至C6炔基，所述取代基团被公式—R4，—R4R5，—O—R4或—S(O)d—R4的基团取代。这些化合物是有用的精神治疗剂，并且是强效的血清素（5-HT1）激动剂和拮抗剂，可用于治疗抑郁症、焦虑症、饮食失调、肥胖、药物滥用、丛集性头痛、偏头痛、疼痛和慢性阵发性偏头痛以及与血管疾病相关的头痛，以及其他由血清素神经传递不足引起的疾病。这些化合物还可用作中枢作用抗高血压药和血管扩张剂。
• Electrochemical dehydrogenative cross-coupling of two anilines: facile synthesis of unsymmetrical biaryls
  作者：Mu-Jia Luo、Yang Li、Xuan-Hui Ouyang、Jin-Heng Li、De-Liang He

  DOI：10.1039/c9cc09879h

  日期：——

  A new, general ortho/para-selective anodic dehydrogenative cross-coupling of two aryl amines, naphthalen-2-amine derivatives and anilines, is described. This electrochemical protocol assembles a wide range of unsymmetrical biaryls in good to excellent yields under mild, additional-metal-catalyst-free, oxidant-free conditions with excellent selectivity, broad substrate scope, and wide functional group

  描述了两种芳基胺，萘-2-胺衍生物和苯胺的新的一般的邻/对选择性阳极脱氢交叉偶联。该电化学方案可在温和的，无附加金属催化剂，无氧化剂的条件下，以优异的选择性，宽泛的底物范围和宽泛的官能团耐受性，以良好的产率组装各种不对称的联芳基。通过将重要的药效基团容易地掺入到最终的联芳基中，这一电化学技术得到了突显，并且适用于苯胺的均偶联以生产对称的联芳基。
• Nickel-Catalyzed Amination of Aryl Phosphates through Cleaving Aryl C–O Bonds
  作者：Jin-Hua Huang、Lian-Ming Yang

  DOI：10.1021/ol201437g

  日期：2011.7.15

  amination of triaryl phosphates was achieved using a Ni(II)–(σ-Aryl) complex/NHC catalyst system in dioxane at 110 °C in the presence of NaH as base. Electron-neutral, -rich, and -deficient triaryl phosphates were coupled with a wider range of amine partners including cyclic and acyclic secondary amines, aliphatic primary amines, and anilines in good to excellent yields.

  磷酸三芳基酯的胺化反应是通过使用Ni（II）-（σ-芳基）络合物/ NHC催化剂体系在二恶烷中于110°C，以NaH为碱的情况下实现的。电子中性的，富含和缺乏的磷酸三芳基酯与多种胺伙伴（包括环状和非环状仲胺，脂族伯胺和苯胺）的偶联效果良好或优异。
• 6π/10π-Electrocyclization of ketene-iminium salts for the synthesis of substituted naphthylamines
  作者：Emmanuelle Villedieu-Percheron、Saron Catak、Didier Zurwerra、Roman Staiger、Mathilde Lachia、Alain De Mesmaeker

  DOI：10.1016/j.tetlet.2014.02.135

  日期：2014.4

  from ketene-iminium salts was developed for the preparation of naphthylamines. Various substituents on the nitrogen, on the aromatic ring, and on the olefin were studied. Tricyclic skeletons were obtained in few steps and good overall yields. The electrocyclization of ketene-iminium salts has been computationally explored by means of DFT calculations and their activation barriers were compared to the

  从乙烯酮-亚胺盐的分子内6π/10π电环化被开发用于萘胺的制备。研究了氮，芳环和烯烃上的各种取代基。三环骨架仅需几个步骤即可获得，并具有良好的整体收率。烯酮-亚胺盐的电环化已经通过DFT计算进行了探索，并且将它们的活化势垒与母体三烯以及相应的二烯基烯丙基和二烯基烯酮进行了比较。乙烯酮-亚胺盐的电环化显示出很高的能量，并且对活化的阻隔性小得多。
• Naphthalene derivatives
  申请人：Chenard L. Bertrand

  公开号：US20050080090A1

  公开（公告）日：2005-04-14

  Compounds of the formula (1) where R 1 is of formula (II), (III), or (IV), or (V); R 2 is —R 4 , —O—R 4 , —O—S(O) 2 —R 4 , —NR 4 R 5 , R 4 —(CH 2 ) b —NH(C═X)—(CH 2 )C—, R 4 —(CH 2 ) b —O(C—O)NH—(CH 2 ) c —(C═O)NH—, R 4 —(C═O)NH—(C═O)NH—, —CH 2 ) b —NH(C═X)—(CH 2 ) c —R 4 , R 4 —(CH 2 ) b —O(C═O)CH 2 ) c —, —(CH 2 ) b —O(C═O)—(CH 2 ) c —R 4 , —NH(C═X)NH—R 4 , R 4 —O(C═O)O—, —O(C═O)NH—R 4 , R 4 —O(C═O)NH—, —(CH 2 ) b —(C═O—(CH 2 ) c —R 4 , —NH—S(O) 2 —R 4 , —C(OH)R 4 R 5 , —CH(OH)—R 4 , —(C═O)—NR 4 , —CN, —NO 2 , substituted C 1 to C 6 alkyl, substituted or unsubstituted C 1 to C 6 alkenyl, or substituted or unsubstituted C 1 to C 6 alkynyl, said substituted moieties substituted with a moiety of the formula —R 4 , —R 4 R 5 , —O—R 4 , or —S(O) d —R 4 ; R 3 is hydrogen, C 1 to C 6 alkyl, C 1 to C 6 alkylaryl, or aryl; R 4 and R 5 are each independently (XV), (XVI), (XVII), (XVII) hydrogen, —CF 3 , C 1 to C 6 alkyl, C 1 to C 6 alkylaryl, with the proviso that when R 2 is —R 4 or —OR 4 , R 4 is not hydrogen or C 1 to C 6 alkyl these compounds are useful psychotherapeutics and are potent serotonin (5-HT 1 ) agonists and antagonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.

  化合物的公式（1），其中R1为公式（II），（III），（IV）或（V）的形式；R2为-R4，-O-R4，-O-S（O）2-R4，-NR4R5，R4-（CH2）b-NH（C═X）-（CH2）c-，R4-（CH2）b-O（C-O）NH-（CH2）c-（C═O）NH-，R4-（C═O）NH-（C═O）NH-，-CH2）b-NH（C═X）-（CH2）c-R4，R4-（CH2）b-O（C═O）CH2）c-，-（CH2）b-O（C═O）-（CH2）c-R4，-NH（C═X）NH-R4，R4-O（C═O）O-，-O（C═O）NH-R4，R4-O（C═O）NH-，-（CH2）b-（C═O-（CH2）c-R4，-NH-S（O）2-R4，-C（OH）R4R5，-CH（OH）-R4，-（C═O）-NR4，-CN，-NO2，取代的C1到C6烷基，取代的或未取代的C1到C6烯基，或取代的或未取代的C1到C6炔基，所述取代基以公式-R4，-R4R5，-O-R4或-S（O）d-R4为取代基；R3为氢，C1到C6烷基，C1到C6烷基芳基或芳基；R4和R5各自独立为（XV），（XVI），（XVII），（XVII）氢，-CF3，C1到C6烷基，C1到C6烷基芳基，但当R2为-R4或-OR4时，R4不是氢或C1到C6烷基，这些化合物是有用的心理治疗药物，是有效的5-羟色胺（5-HT1）激动剂和拮抗剂，可用于治疗抑郁症，焦虑症，进食障碍，肥胖症，药物滥用，集群头痛，偏头痛，疼痛和慢性阵发性半头痛和与血管障碍相关的头痛以及其他由5-羟色胺能神经递质缺乏引起的疾病。这些化合物也可用作中枢作用的降压药和血管扩张剂。